Federal health advisers have voted against a Merck proposal to sell its prescription respiratory pill Singulair as an over-the-counter allergy medication. The Food and Drug Administration’s panel of experts voted 11-4 today against making the drug available without a prescription. Merck sells Singulair via prescription for asthma and allergies. Singulair was once Merck’s best-selling drug, but sales have plummeted since the drug’s patent expired in mid-2012, exposing the brand to low cost generics.
Help employers find you! Check out all the jobs and post your resume.
